心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

经导管主动脉瓣置换团队建设及运行规范中国专家建议

2018-01-30 中国医师协会心血管内科医师分会 中国医学前沿杂志（电子版）.2018,10(1):19-23.

经导管主动脉瓣置换团队建设运行规范

经导管主动脉瓣置换术（transcathetera ortic valve replacement，TAVR）是指将组装好的人工主动脉瓣经导管植入到病变的主动脉瓣处，在功能上完成主动脉瓣的置换。TAVR 是治疗主动脉瓣狭窄的革命性新技术，目前欧美指南已推荐将外科手术禁忌、高危和中危主动脉瓣狭窄患者作为TAVR的适应证。TAVR 同时也是一种复杂、高风险的技术，其开展需心内科、心外科、影像科、麻醉科

中文标题：

经导管主动脉瓣置换团队建设及运行规范中国专家建议

发布机构：

中国医师协会心血管内科医师分会

发布日期：

2018-01-30

简要介绍：

经导管主动脉瓣置换术（transcathetera ortic valve replacement，TAVR）是指将组装好的人工主动脉瓣经导管植入到病变的主动脉瓣处，在功能上完成主动脉瓣的置换。TAVR 是治疗主动脉瓣狭窄的革命性新技术，目前欧美指南已推荐将外科手术禁忌、高危和中危主动脉瓣狭窄患者作为TAVR的适应证。TAVR 同时也是一种复杂、高风险的技术，其开展需心内科、心外科、影像科、麻醉科等多学科的协同配合，因此很有必要建立一支多学科心脏团队（multiple disciplinary heart team，MDHT）。国产TAVR 瓣膜近期已于我国获批上市，TAVR 将在我国大范围地推广。为了促进TAVR 在我国规范、安全、顺利地推广，中国医师协会心血管内科医师分会结构性心脏病专业委员会和中华医学会心血管病学分会结构性心脏病学组组织编写了此建议。本建议主要针对经外周血管途径的TAVR而编写。

 

拓展指南：与主动脉瓣相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=经导管主动脉瓣置换团队建设及运行规范中国专家建议)] GetToolGuiderByIdResponse(projectId=1, id=23eff1c001556108, title=经导管主动脉瓣置换团队建设及运行规范中国专家建议, enTitle=, guiderFrom=中国医学前沿杂志（电子版）.2018,10(1):19-23., authorId=null, author=, summary=经导管主动脉瓣置换术（transcathetera ortic valve replacement，TAVR）是指将组装好的人工主动脉瓣经导管植入到病变的主动脉瓣处，在功能上完成主动脉瓣的置换。TAVR 是治疗主动脉瓣狭窄的革命性新技术，目前欧美指南已推荐将外科手术禁忌、高危和中危主动脉瓣狭窄患者作为TAVR的适应证。TAVR 同时也是一种复杂、高风险的技术，其开展需心内科、心外科、影像科、麻醉科, cover=, journalId=null, articlesId=null, associationId=315, associationName=中国医师协会心血管内科医师分会, associationIntro=null, copyright=0, guiderPublishedTime=Tue Jan 30 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>经导管主动脉瓣置换术（transcathetera ortic valve replacement，TAVR）是指将组装好的人工主动脉瓣经导管植入到病变的主动脉瓣处，在功能上完成主动脉瓣的置换。TAVR 是治疗主动脉瓣狭窄的革命性新技术，目前欧美指南已推荐将外科手术禁忌、高危和中危主动脉瓣狭窄患者作为TAVR的适应证。TAVR 同时也是一种复杂、高风险的技术，其开展需心内科、心外科、影像科、麻醉科等多学科的协同配合，因此很有必要建立一支多学科心脏团队（multiple disciplinary heart team，MDHT）。国产TAVR 瓣膜近期已于我国获批上市，TAVR 将在我国大范围地推广。为了促进TAVR 在我国规范、安全、顺利地推广，中国医师协会心血管内科医师分会结构性心脏病专业委员会和中华医学会心血管病学分会结构性心脏病学组组织编写了此建议。本建议主要针对经外周血管途径的TAVR而编写。 </P> <P> </P>拓展指南：<strong>与<font color=red>主动脉瓣</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=799171c001a11284" title="2017 EACVI/ASE建议：超声心动图评估主动脉瓣狭窄（更新）" target=_blank>2017 EACVI/ASE建议：超声心动图评估主动脉瓣狭窄（更新）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=91f211c0013826a5" title="主动脉瓣病变处理指南新解" target=_blank>主动脉瓣病变处理指南新解</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=a7ef41c0013a03a2" title="主动脉瓣狭窄微创腔内治疗专家共识" target=_blank>主动脉瓣狭窄微创腔内治疗专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=b0acb1c0012e50a6" title="2015 经导管主动脉瓣置换术中国专家共识" target=_blank>2015 经导管主动脉瓣置换术中国专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=379261c00125a1c1" title="2015 经导管主动脉瓣置换术期间全面超重心动图检查建议" target=_blank>2015 经导管主动脉瓣置换术期间全面超重心动图检查建议</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E4%B8%BB%E5%8A%A8%E8%84%89%E7%93%A3" target=_blank>有关主动脉瓣更多指南</a></ul>, tagList=[TagDto(tagId=7792, tagName=经导管主动脉瓣置换), TagDto(tagId=70257, tagName=团队建设), TagDto(tagId=70258, tagName=运行规范)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3856, appHits=160, showAppHits=0, pcHits=2729, showPcHits=1359, likes=119, shares=4, comments=11, approvalStatus=1, publishedTime=Fri Feb 16 20:27:57 CST 2018, publishedTimeString=2018-01-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Feb 16 20:27:57 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 10:32:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=经导管主动脉瓣置换团队建设及运行规范中国专家建议)])
经导管主动脉瓣置换团队建设及运行规范中国专家建议
下载请点击：
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=289477, encodeId=a9282894e713, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Feb 20 18:25:29 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289247, encodeId=6de228924e4f, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Feb 19 21:18:12 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289225, encodeId=68fb2892257d, content=经导管主动脉瓣置换术(transcathetera ortic valve replacement.TAVR)是指将组装好的人工主动脉瓣经导管植入到病变的主动脉瓣处.在功能上完成主动脉瓣的置换.TAVR 是治疗主动脉瓣狭窄的革命性新技术.目前欧美指南已推荐将外科手术禁忌.高危和中危主动脉瓣狭窄患者作为TAVR的适应证.TAVR 同时也是一种复杂.高风险的技术.其开展需心内科.心外科.影像科.麻醉科等多学科的协同配合.因此很有必要建立一支多学科心脏团队(multiple disciplinary heart team.MDHT).国产TAVR 瓣膜近期已于我国获批上市.TAVR 将在我国大范围地推广., beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon Feb 19 20:14:02 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288609, encodeId=161e2886097b, content=厉害了我的哥, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Feb 17 08:28:42 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288577, encodeId=aad92885e7ad, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sat Feb 17 07:40:28 CST 2018, time=2018-02-17, status=1, ipAttribution=)]
    2018-02-20 131****1460

    学习了受益匪浅

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=289477, encodeId=a9282894e713, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Feb 20 18:25:29 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289247, encodeId=6de228924e4f, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Feb 19 21:18:12 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289225, encodeId=68fb2892257d, content=经导管主动脉瓣置换术(transcathetera ortic valve replacement.TAVR)是指将组装好的人工主动脉瓣经导管植入到病变的主动脉瓣处.在功能上完成主动脉瓣的置换.TAVR 是治疗主动脉瓣狭窄的革命性新技术.目前欧美指南已推荐将外科手术禁忌.高危和中危主动脉瓣狭窄患者作为TAVR的适应证.TAVR 同时也是一种复杂.高风险的技术.其开展需心内科.心外科.影像科.麻醉科等多学科的协同配合.因此很有必要建立一支多学科心脏团队(multiple disciplinary heart team.MDHT).国产TAVR 瓣膜近期已于我国获批上市.TAVR 将在我国大范围地推广., beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon Feb 19 20:14:02 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288609, encodeId=161e2886097b, content=厉害了我的哥, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Feb 17 08:28:42 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288577, encodeId=aad92885e7ad, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sat Feb 17 07:40:28 CST 2018, time=2018-02-17, status=1, ipAttribution=)]
    2018-02-19 1e1b8538m79(暂无匿称)

    不错的文章值得拥有哦

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=289477, encodeId=a9282894e713, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Feb 20 18:25:29 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289247, encodeId=6de228924e4f, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Feb 19 21:18:12 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289225, encodeId=68fb2892257d, content=经导管主动脉瓣置换术(transcathetera ortic valve replacement.TAVR)是指将组装好的人工主动脉瓣经导管植入到病变的主动脉瓣处.在功能上完成主动脉瓣的置换.TAVR 是治疗主动脉瓣狭窄的革命性新技术.目前欧美指南已推荐将外科手术禁忌.高危和中危主动脉瓣狭窄患者作为TAVR的适应证.TAVR 同时也是一种复杂.高风险的技术.其开展需心内科.心外科.影像科.麻醉科等多学科的协同配合.因此很有必要建立一支多学科心脏团队(multiple disciplinary heart team.MDHT).国产TAVR 瓣膜近期已于我国获批上市.TAVR 将在我国大范围地推广., beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon Feb 19 20:14:02 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288609, encodeId=161e2886097b, content=厉害了我的哥, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Feb 17 08:28:42 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288577, encodeId=aad92885e7ad, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sat Feb 17 07:40:28 CST 2018, time=2018-02-17, status=1, ipAttribution=)]
    2018-02-19 有备才能无患

    经导管主动脉瓣置换术(transcathetera ortic valve replacement.TAVR)是指将组装好的人工主动脉瓣经导管植入到病变的主动脉瓣处.在功能上完成主动脉瓣的置换.TAVR 是治疗主动脉瓣狭窄的革命性新技术.目前欧美指南已推荐将外科手术禁忌.高危和中危主动脉瓣狭窄患者作为TAVR的适应证.TAVR 同时也是一种复杂.高风险的技术.其开展需心内科.心外科.影像科.麻醉科等多学科的协同配合.因此很有必要建立一支多学科心脏团队(multiple disciplinary heart team.MDHT).国产TAVR 瓣膜近期已于我国获批上市.TAVR 将在我国大范围地推广.

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=289477, encodeId=a9282894e713, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Feb 20 18:25:29 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289247, encodeId=6de228924e4f, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Feb 19 21:18:12 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289225, encodeId=68fb2892257d, content=经导管主动脉瓣置换术(transcathetera ortic valve replacement.TAVR)是指将组装好的人工主动脉瓣经导管植入到病变的主动脉瓣处.在功能上完成主动脉瓣的置换.TAVR 是治疗主动脉瓣狭窄的革命性新技术.目前欧美指南已推荐将外科手术禁忌.高危和中危主动脉瓣狭窄患者作为TAVR的适应证.TAVR 同时也是一种复杂.高风险的技术.其开展需心内科.心外科.影像科.麻醉科等多学科的协同配合.因此很有必要建立一支多学科心脏团队(multiple disciplinary heart team.MDHT).国产TAVR 瓣膜近期已于我国获批上市.TAVR 将在我国大范围地推广., beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon Feb 19 20:14:02 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288609, encodeId=161e2886097b, content=厉害了我的哥, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Feb 17 08:28:42 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288577, encodeId=aad92885e7ad, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sat Feb 17 07:40:28 CST 2018, time=2018-02-17, status=1, ipAttribution=)]
    2018-02-17 飛歌

    厉害了我的哥

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=289477, encodeId=a9282894e713, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Feb 20 18:25:29 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289247, encodeId=6de228924e4f, content=不错的文章值得拥有哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Feb 19 21:18:12 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=289225, encodeId=68fb2892257d, content=经导管主动脉瓣置换术(transcathetera ortic valve replacement.TAVR)是指将组装好的人工主动脉瓣经导管植入到病变的主动脉瓣处.在功能上完成主动脉瓣的置换.TAVR 是治疗主动脉瓣狭窄的革命性新技术.目前欧美指南已推荐将外科手术禁忌.高危和中危主动脉瓣狭窄患者作为TAVR的适应证.TAVR 同时也是一种复杂.高风险的技术.其开展需心内科.心外科.影像科.麻醉科等多学科的协同配合.因此很有必要建立一支多学科心脏团队(multiple disciplinary heart team.MDHT).国产TAVR 瓣膜近期已于我国获批上市.TAVR 将在我国大范围地推广., beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Mon Feb 19 20:14:02 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288609, encodeId=161e2886097b, content=厉害了我的哥, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Feb 17 08:28:42 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288577, encodeId=aad92885e7ad, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sat Feb 17 07:40:28 CST 2018, time=2018-02-17, status=1, ipAttribution=)]
    2018-02-17 清风拂面

    谢谢分享学习

    0

以上为热门评论，梅斯医学App还有更多内容